Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Watson W. Mark, Director. Director active across 3 companies, notably Vaxart, Inc.. In total, 14 disclosures have been published. Breakdown: 4 buys · 0 sell. Total volume traded: €36k. History available since 19 May 2021. The latest transaction was filed on 16 July 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Watson W. Mark
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
694 shares@ US$41.43100.0% of flowCommon StockSEC:0001127602-21-017319:0
14 of 14 declarations
About Watson W. Mark
Mark Watson is a Director at Vaxart, Inc., SYKES ENTERPRISES INC, and BIODELIVERY SCIENCES INTERNATIONAL INC. He plays a key role in the governance of these companies, contributing to strategic decision-making and overseeing operations. His diverse experience is valuable in guiding these organizations towards their objectives.